Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker’s blockbuster Gardasil cancer vaccine for ...
Beginning in September 2012, the UK’s National Health System will replace Ceverex, produced by GlaxoSmithKline(NYSE:GSK), with Gardasil from Merck (NYSE: MRK) for its HPV vaccine program, the health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results